Chordia Therapeutics Inc. (TYO:190A)
Japan · Delayed Price · Currency is JPY 125.00
-5.00 (-3.85%)
Apr 3, 2026, 3:30 PM JST
Chordia Therapeutics Market Cap
Chordia Therapeutics has a market cap or net worth of 9.12 billion as of April 2, 2026. Its market cap has decreased by -45.00% in one year.
Market Cap
9.12B
Enterprise Value
6.78B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
125.00
Market Cap Chart
Since June 14, 2024, Chordia Therapeutics's market cap has decreased from 12.58B to 9.12B, a decrease of -27.56%. That is a compound annual growth rate of -16.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 3, 2026 | 9.12B | 22.35% |
| Dec 30, 2025 | 7.45B | -65.16% |
| Dec 30, 2024 | 21.39B | 69.94% |
| Jun 14, 2024 | 12.58B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Qol Holdings | 71.77B |
| Cawachi | 67.67B |
| Shinnihonseiyaku | 44.05B |
| Heartseed | 41.60B |
| YAKUODO HOLDINGS | 37.25B |
| Astena Holdings | 19.50B |
| Ohki Healthcare Holdings | 18.54B |
| Medical System Network | 16.22B |